Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,857 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05623267RecruitingPhase 2/Phase 3
SugeMalimab after lung radiation and chemotherapy for limited-stage SCLC
This trial tests sugemalimab as “extra treatment” after standard chemoradiation for limited-stage small cell lung cancer. It aims to lower the chance of the cancer coming back by helping the immune system stay active after initial therapy.
Guangzhou, GuangdongAges 18 years+ - NCT05623176Recruiting
Study fairness in emergency surgery care during emergency laparotomy
This study looks at outcomes and whether emergency general surgery care is delivered fairly. It may help improve how hospitals support people having urgent abdominal surgery.
StockholmAges 16 years+ - NCT05623514Recruiting
Ultrasound to better choose vNOTES surgery patients
This study looks at using an ultrasound scan to help doctors choose which patients may be good candidates for a type of vaginal surgery called vNOTES. It may help improve safety and outcomes by matching the right patients to the right approach.
Houston, TexasAges 18 years+ - NCT05623722Recruiting
Nerve block to help organ function in severe gut sepsis
This trial studies whether an erector spinae plane nerve block (a pain-control injection near the spine) can improve organ health in adults with sepsis caused by acute gut injury. It’s meant for people sick enough to need ICU care for several days.
Guangzhou, GuangdongAges 18 years+ - NCT05623982RecruitingPhase 1/Phase 2
Study drug for lymphoma that has returned or did not respond
This Phase 1/2 study tests an injection called GNC-038 in people with non-Hodgkin’s lymphoma that has come back or is resistant to treatment. It aims to see how well the drug works and how safe it is for this group.
Beijing, Beijing MunicipalityAges 18–75 - NCT05624398Recruiting
Hydrus stent plus cataract surgery for mild glaucoma
This study looks at outcomes for people with mild glaucoma who need cataract surgery, comparing how well the Hydrus stent works when placed during cataract surgery. The goal is to see whether this combined approach keeps eye pressure and vision stable with fewer issues.
Fayetteville, ArkansasAges 45 years+ - NCT05625750Recruiting
Study of people diagnosed with fatty liver from not-too-much alcohol
This is an observational study for people diagnosed with nonalcoholic fatty liver disease (fatty buildup in the liver not mainly caused by heavy drinking). It may help researchers better understand this condition, especially how it shows up on tests and how people report relevant health information.
Changsha, HunanAges 18–75 - NCT05626348RecruitingPhase 4
Test immune-modulator treatments for rheumatoid arthritis with knee trouble
This Phase 4 trial studies whether immune-modulator medicines improve symptoms and function in people with rheumatoid arthritis who have knee problems. It may also compare responses in osteoarthritis and healthy volunteers, depending on the group you fit.
Jinan, ShandongAges 18–80 - NCT05626712RecruitingPhase 1/Phase 2
CELZ-201 to preserve insulin production in early type 1 diabetes
This Phase 1/2 study tests whether CELZ-201 is safe and can help the body keep making some of its own insulin in people who were recently diagnosed with type 1 diabetes. You may be eligible if your diabetes started within the past year and your tests show you still have some insulin-making activity.
Miami, FloridaAges 18–35 - NCT05627375RecruitingPhase 3
Blood thinner options for clot patients already on antiplatelets
This Phase 3 trial compares the best “blood thinner” approach for people who have a new clot in the leg (DVT) or lung (PE) and who already take antiplatelet medicines for heart or blood-vessel prevention. It aims to find an antithrombotic plan that lowers clot risk while managing bleeding risk.
AmiensAges 18 years+ - NCT05627492Recruiting
DBT booster sessions for youth at bipolar risk
This study adds short “booster” sessions to Dialectical Behavior Therapy (DBT) for young people who already took part in a prior DBT study, including those with bipolar symptoms or strong family risk. It aims to see if extra DBT support helps mood and coping over time.
Toronto, OntarioAges 14–25 - NCT05629104Recruiting
Predicting long-term outcomes after aortic valve procedure
This study follows people who have aortic valve treatment to better predict how they will do in the long term. It may help doctors understand what outcomes to expect after the procedure and improve future care.
UppsalaAges 18 years+ - NCT05629689RecruitingPhase 1
PET scan drug check for people with solid tumors
This Phase 1 study tests whether an investigational PET scan tracer is safe and tolerable when used for PET imaging in people with certain solid cancers. It mainly looks at side effects and how well the scan can be done, not whether it treats cancer.
AmsterdamAges 18 years+ - NCT05629845Recruiting
Prevent repeat stomach bleeding using an ultrasound-guided scope
This study compares two ways to stop variceal bleeding (bleeding from swollen veins in the esophagus or stomach) from coming back in people with liver cancer. It tests whether an ultrasound-guided technique during endoscopy can reduce repeat bleeding compared with standard endoscopy methods.
Shatin, New TerritoriesAges 18 years+ - NCT05630651Recruiting
ZS801 for adults with severe hemophilia B
This trial studies ZS801, a gene therapy, in adults with hemophilia B who have very low natural FIX (a clotting protein) and frequent bleeding or joint problems. It aims to see how well it works and whether it is safe, especially by monitoring blood counts, infections, and immune responses.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT05632497Recruiting
Testing gut microbiome changes in adults with anorexia
This study looks at how changing the gut bacteria (microbiome) may affect people hospitalized for anorexia nervosa. You may be eligible if you’re an adult with a very low BMI and meet the study’s timing and health requirements.
VillejuifAges 18 years+ - NCT05632419Recruiting
Study of extreme agitation and what it predicts
This trial looks at people who show “extreme agitation” in order to better predict what may happen next. It mainly involves observation to understand the possible causes and likely outcomes of severe agitation.
Bobigny, Île-de-France RegionAges 18 years+ - NCT05632757Recruiting
Studying support for ALS patients and their family caregivers
This study looks at how much burden (stress and day-to-day strain) ALS creates for both the patient and the main caregiver. It may help shape better ways to support families facing ALS over time.
MarseilleAges 18 years+ - NCT05633628Recruiting
Wear a continuous glucose monitor with type 2 diabetes
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
StockholmAges 18–80 - NCT05634200Recruiting
Testing bronchoscopy after unexplained coughing blood
This trial studies whether looking inside the airways with a bronchoscopy can find the cause of coughing blood when a chest CT scan is negative or unclear. It may help doctors identify the bleeding source that earlier scans did not show.
BergamoAges 18 years+ - NCT05634057Recruiting
Treating sepsis with a medication plus blood thinner
This trial studies whether combining anisodamine (a medicine for certain gut/smooth-muscle effects) with a low-molecular-weight blood thinner helps treat sepsis. It may be aimed at improving outcomes compared with standard care, but eligibility depends on safety factors like bleeding risk and organ function.
Beijing, ChinaAges 18–110 - NCT05633810RecruitingPhase 3
Testing colchicine plus coated aspirin to prevent heart events
This Phase 3 study tests whether colchicine and a special type of aspirin can lower the risk of future heart attacks, strokes, or other major heart problems in people with type 2 diabetes who have not had a prior heart event. It aims to reduce cardiovascular risk using medicines that may calm inflammation and protect blood vessels.
Bentley, Western AustraliaAges 55–80 - NCT05634109RecruitingPhase 3
Whole blood to treat adults with severe bleeding trauma
This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.
Cali, Valle del Cauca DepartmentAges 18 years+ - NCT05634889Recruiting
Personalized breast radiation for limited lymph-node spread
This trial studies a tailored form of radiation treatment for some people with early breast cancer whose sentinel lymph-node biopsy shows cancer in 1–2 nodes. It may help improve local control while guiding the best radiation approach for your specific situation.
HelsinkiAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,857 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.